BioSpace News Archive

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global medical holography market is anticipated to reach US$ 3.5 billion by the end of 2026 in comparison to US$ 447.8 million valuation in 2019.

Growth in the prevalence of sport-related injuries across major parts of the globe is anticipated to drive demand opportunities in the global ACL reconstruction market during the forecast period of 2021 to 2031.

Fact.MR – A Market Research and Competitive Intelligence Provider: As per Fact.MR, the global endoscopic clips market is estimated to grow at a CAGR of 7.3%, totaling US$ 617.0 Mn by the end of 2026.

OSE Immunotherapeutics will host a virtual R&D Day on Tuesday, October 12th, 2021 at 4:00 p.m. CEST/ 10:00 a.m. EDT.

MiNA Therapeutics Limited, the pioneer in small activating RNA therapeutics, announces that it has significantly expanded its senior leadership team with four new appointments to support the Company’s next phase of growth.

Cytokine storm and coagulopathy, the major life-threatening complications of COVID-19, whose biomarkers Interleukin-6 and D-Dimer were under control with consumption of two variants of Nichi Glucan food supplements from Japan in a pilot study.

Genematrix, specialized in real-time PCR based molecular diagnostics, announced that ‘NeoPlex™ HPV29 Detection’, which can collectively diagnose 29 genotypes of human papillomavirus and simultaneously identify the virus genotype according to the risk of cervical cancer, acquired European Medical Device Certification.

RepliCel Life Sciences Inc., a company developing next-generation technologies in aesthetics and orthopedics, is pleased to announce that Kunihiko Suzuki has agreed to accept an appointment as a Senior Strategic Advisor to its Board of Directors with a particular focus on building the Company’s enterprise in Japan.

Quest Diagnostics Incorporated, the world’s leading provider of diagnostic information services, has completed its integration of Northeast regional operations to its new 250,000 sq. ft. next-generation lab facility in Clifton, NJ.

Johnson & Johnson announced that Paul Stoffels M.D., currently Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson, will retire from the Company effective December 31, 2021.